Date | Price Target | Rating | Analyst |
---|---|---|---|
8/20/2024 | $34.00 | Buy | Needham |
2/26/2024 | $42.00 | Outperform | Leerink Partners |
11/16/2023 | $35.00 | Buy | Needham |
11/10/2023 | Mkt Perform → Outperform | William Blair | |
1/12/2023 | Underperform → Mkt Perform | William Blair | |
8/5/2022 | Mkt Perform → Underperform | William Blair | |
6/2/2022 | $58.00 → $47.00 | Neutral → Buy | UBS |
4/20/2022 | $46.00 | Overweight → Neutral | Piper Sandler |
Dentsply Sirona's next-generation intraoral scanner opens a new era of digital patient care, allowing scanning directly to the cloud on any internet-connected device. Cloud-native, wireless, and highly versatile — this is Primescan 2. Building upon the proven1 scanning technology of Primescan and with the ability to scan directly to the cloud on any internet-connected device, Primescan 2 can help practices expand their treatment offerings, save time in daily workflows, and deliver enhanced care and comfort to their patients. CHARLOTTE, N.C., Sept. 5, 2024 /PRNewswire/ -- Dentsply Sirona (NASDAQ:XRAY) continues to pave the way for the future of digital dentistry with the introduction of a new
CHARLOTTE, N.C., Aug. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its participation at upcoming conferences. Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 9:15 am ETBaird Global Healthcare Conference on September 10, 2024, at 9:40 am ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a
CHARLOTTE, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to assume an executive position at another public company. The Company has initiated a search process to identify its next CFO with the assistance of a leading executive search firm. "On behalf of the entire Dentsply Sirona team, I want to extend our deepest gratitude to Glenn for his leadership and many contributions to our Company over the last two years," said Simon Campion, President and Chief Executive Officer. "During his tenure, Glenn
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%)GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02)Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10)Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common stock in Q3 2024Second phase of transformation includes an expected reduction in annualized operating expenses of $80 to $100 million over approximately 12 to 18 months CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- D
CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, July 31, 2024, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://re
CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 12, 2024, to holders of record as of June 28, 2024. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering including dental and oral health
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
10-Q - DENTSPLY SIRONA Inc. (0000818479) (Filer)
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $33 to $31.
In the preceding three months, 10 analysts have released ratings for Dentsply Sirona (NASDAQ:XRAY), presenting a wide array of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 5 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 3 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 2 3 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $32.5, a high estimate of $38.00, and a low estimate of $27.00. Observing
Stifel analyst Jonathan Block maintains Dentsply Sirona (NASDAQ:XRAY) with a Hold and lowers the price target from $30 to $28.
Needham reiterated coverage of Dentsply Sirona with a rating of Buy and set a new price target of $34.00
Leerink Partners initiated coverage of Dentsply Sirona with a rating of Outperform and set a new price target of $42.00
Needham initiated coverage of Dentsply Sirona with a rating of Buy and set a new price target of $35.00
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
Credo Technology Group Holding Ltd ("Credo" or the "Company") (NASDAQ:CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved power efficiency as data rates and corresponding bandwidth requirements increase throughout the data infrastructure market, today announced the appointment of Clyde Hosein to the Company's board of directors effective April 3, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240401894812/en/Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors (Photo: Business Wire) "Clyde's appointment to the Credo boar
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company's Board of Directors (the "Board") for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election. Mr. Brandt commented, "As I think back on the past two decades and all of the challenges we've navigated together, I am grateful for the talented and dedicated individuals with whom I have had the privilege to serve. I am proud of the strong and diverse Boar